Clorazepate Dipotassium Tablet
Product Images NDC 72789-256

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clorazepate Dipotassium (NDC 72789-256). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789256 Label (72789256)

72789256 Label (72789256)
This is a medication package for Clorazepate Dipotassium USP, containing 6 tablets with each tablet containing 15mg of Clorazepate Dipotassium USP. The package comes with a warning to keep it out of reach of children and instructions to only take it as prescribed by a doctor. It also contains a caution to avoid alcohol while taking the medication as it may cause drowsiness and affect mental alertness. Additionally, users are advised to seek medical advice about possible side effects before taking the medication. The package does not provide detailed dosage and storage information, directing users to refer to the package insert for such information. Users may report side effects to FDA at the provided phone number.*
FDA Label Image

Chemical Structure (Clorazepate 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.